Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective

被引:14
|
作者
Banerjee, Rajashree [1 ]
Rai, Arushi [1 ]
Iyer, Shreyas M. [1 ]
Narwal, Sonia [1 ]
Tare, Meghana [1 ]
机构
[1] Birla Inst Technol & Sci, Dept Biol Sci, Pilani 333031, Rajasthan, India
关键词
Alzheimer's disease; animal models; neurodegeneration; Parkinson's disease; AMYLOID-PRECURSOR-PROTEIN; HUMAN ALPHA-SYNUCLEIN; MULTIPLE SYSTEM TAUOPATHY; MOUSE MODEL; NEUROFIBRILLARY TANGLES; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; GENETIC-ANALYSIS; PRIMATE MODEL; CELL-DEATH;
D O I
10.1002/ame2.12209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alzheimer's disease and Parkinson's disease are two of the most prevalent and disabling neurodegenerative diseases globally. Both are proteinopathic conditions and while occasionally inherited, are largely sporadic in nature. Although the advances in our understanding of the two have been significant, they are far from complete and neither diagnosis nor the current practices in treatment and rehabilitation is adequately helpful. Animal models have historically found application as testing beds for novel therapeutics and continue to be valuable aids in pharmacological research. This review chronicles the development of those models in the context of Alzheimer's and Parkinson's disease, and highlights the shifting paradigms in studying two human-specific conditions in non-human organisms.
引用
收藏
页码:27 / 37
页数:11
相关论文
共 50 条
  • [21] Animal Models of Parkinson's Disease: A Gateway to Therapeutics?
    Le, Weidong
    Sayana, Pavani
    Jankovic, Joseph
    NEUROTHERAPEUTICS, 2014, 11 (01) : 92 - 110
  • [22] Impact of aging on animal models of Parkinson's disease
    Klaestrup, Ida Hyllen
    Just, Mie Kristine
    Holm, Karina Lassen
    Alstrup, Aage Kristian Olsen
    Romero-Ramos, Marina
    Borghammer, Per
    van den Berge, Nathalie
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [23] Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease
    Deng, Isaac
    Corrigan, Frances
    Zhai, Guangxi
    Zhou, Xin-Fu
    Bobrovskaya, Larisa
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2020, 4
  • [24] PET Imaging in Animal Models of Alzheimer's Disease
    Chen, Baosheng
    Marquez-Nostra, Bernadette
    Belitzky, Erika
    Toyonaga, Takuya
    Tong, Jie
    Huang, Yiyun
    Cai, Zhengxin
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [25] α-Syrtuclein, Parkinson's disease, and Alzheimer's disease
    Kim, SH
    Seo, JH
    Suh, YH
    PARKINSONISM & RELATED DISORDERS, 2004, 10 : S9 - S13
  • [26] Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease
    Verma, Aanchal
    Chaudhary, Shobhit
    Solanki, Kunal
    Goyal, Ahsas
    Yadav, Harlokesh Narayan
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 103 (01)
  • [27] On a New Paradigm of the Development of Neurodegenerative Diseases by the Example of Alzheimer's Disease and Parkinson's Disease
    Litvinenko, I. V.
    Lobzin, V. Yu.
    ADVANCES IN GERONTOLOGY, 2022, 12 (04) : 386 - 395
  • [28] Neurotoxins as Preclinical Models for Parkinson's Disease
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2018, 34 (04) : 870 - 877
  • [29] Genetic Animal Models of Parkinson's Disease
    Dawson, Ted M.
    Ko, Han Seok
    Dawson, Valina L.
    NEURON, 2010, 66 (05) : 646 - 661
  • [30] Animal Models of Alzheimer's Disease: An Understanding of Pathology and Therapeutic Avenues
    Obulesu, M.
    Rao, Dowlathabad Muralidhara
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (08) : 531 - 537